Delatestryl
Please select a testosterone article from the list below:
- M2 Presswire - Morning Alert for Indevus Pharmaceuticals Inc.
- M2 Presswire - Current Research on Indevus Pharmaceuticals Inc.
- M2 Presswire - Indevus Pharmaceuticals Inc is Added to the Bellwether Watch list.
- M2 Presswire - Analysis of Indevus Pharmaceuticals Inc.
- M2 Presswire - Fundamental Review for Indevus Pharmaceuticals Inc.
- Business Wire - Savient Pharmaceuticals Closes Sale of Delatestryl® Product to Indevus Pharmaceuticals
- Business Wire - Indevus Announces Closing of Delatestryl® Transaction
- Business Wire - Savient Pharmaceuticals Agrees to Sale of Delatestryl® to Indevus Pharmaceuticals
- Business Wire - Indevus Pharmaceuticals Announces Fiscal 2005 Year End and Fourth Quarter Results; Company Acquires Rights to Delatestryl®; Company Finalizes NDA Submission Plans for NEBIDO®
- Business Wire - Savient Pharmaceuticals, Inc. Announces FDA Approval of New Manufacturing Site for Delatestryl, Savient's Injectable Testosterone Product
Wednesday 27th of June 2007
M2 Presswire - Morning Alert for Indevus Pharmaceuticals Inc.
Wednesday 27th of June 2007, 4:59 pmJune 27, 2007 -- M2 PRESSWIRE-27 June 2007-Biotech News: Morning Alert for Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:27062007...
Thursday 7th of June 2007
M2 Presswire - Current Research on Indevus Pharmaceuticals Inc.
Thursday 7th of June 2007, 4:59 pmJune 7, 2007 -- M2 PRESSWIRE-7 June 2007-Biotech News: Current Research on Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:07062007...
Monday 26th of March 2007
M2 Presswire - Indevus Pharmaceuticals Inc is Added to the Bellwether Watch list.
Monday 26th of March 2007, 4:59 pmMarch 26, 2007 -- M2 PRESSWIRE-26 March 2007-Biotech News: Indevus Pharmaceuticals Inc is Added to the Bellwether Watch list(C)1994-2007 M2 COMMUNICATIONS LTD...
Friday 2nd of March 2007
M2 Presswire - Analysis of Indevus Pharmaceuticals Inc.
Friday 2nd of March 2007, 3:59 pmMarch 2, 2007 -- M2 PRESSWIRE-2 March 2007-Biotech News: Analysis of Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:02032007 Analysis of...
Tuesday 12th of December 2006
M2 Presswire - Fundamental Review for Indevus Pharmaceuticals Inc.
Tuesday 12th of December 2006, 3:59 pmDecember 12, 2006 -- M2 PRESSWIRE-12 December 2006-Biotech News: Fundamental Review for Indevus Pharmaceuticals Inc(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:12122006...
Monday 9th of January 2006
Business Wire - Savient Pharmaceuticals Closes Sale of Delatestryl® Product to Indevus Pharmaceuticals
Monday 9th of January 2006, 3:59 pmJanuary 9, 2006 -- Savient Pharmaceuticals Closes Sale of Delatestryl(R) Product to Indevus Pharmaceuticals. EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc....
Business Wire - Indevus Announces Closing of Delatestryl® Transaction
Monday 9th of January 2006, 3:59 pmJanuary 9, 2006 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced the closing of the previously announced acquisition of the U.S....
Tuesday 13th of December 2005
Business Wire - Savient Pharmaceuticals Agrees to Sale of Delatestryl® to Indevus Pharmaceuticals
Tuesday 13th of December 2005, 3:59 pmDecember 13, 2005 -- EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNTE) an emerging specialty pharmaceuticals company focused on developing,...
Business Wire - Indevus Pharmaceuticals Announces Fiscal 2005 Year End and Fourth Quarter Results; Company Acquires Rights to Delatestryl®; Company Finalizes NDA Submission Plans for NEBIDO®
Tuesday 13th of December 2005, 3:59 pmDecember 13, 2005 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced its consolidated results of operations for the fiscal year and the...
Monday 8th of September 2003
Business Wire - Savient Pharmaceuticals, Inc. Announces FDA Approval of New Manufacturing Site for Delatestryl, Savient's Injectable Testosterone Product
Monday 8th of September 2003, 4:59 pmSeptember 8, 2003 -- Business Editors/Health/Medical Writers Business Editors/Health/Medical Writers BIOWIRE2K EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 8,...